Company facts
- Headquarters
- San Carlos, California
- Most recent report
- 10-Q, filed Sep 2, 2026
- Incorporated
- Delaware
- Filings on record
- 56 filings
- On EDGAR
- CIK 2058707
- Fiscal year ends
- December
- Filer status
- Non-accelerated filer, Smaller reporting company, Emerging growth company
Financials 1
News 2
Prospectuses and Registrations 5
Ownership 8 of 42
- 4/A Insider reported a trade, amended Oct 8, 2026
- 4/A Insider reported a trade, amended Oct 8, 2026
- 3/A Insider reported their initial holding, amended Oct 8, 2026
- 3/A Insider reported their initial holding, amended Oct 8, 2026
- 144 Notice of a proposed sale of restricted stock Aug 28, 2026
- 4/A Insider reported a trade, amended Aug 28, 2026
- 4/A Insider reported a trade, amended Aug 28, 2026
- 4 Insider reported a trade Aug 13, 2026
Other 6
- EFFECT Notice that a registration became effective Aug 4, 2026
- CERT Exchange certified a listing Aug 4, 2026
- 8-A12B Registration of a security for exchange listing Jul 29, 2026
- DRS/A Draft registration statement, submitted confidentially, amended Jun 5, 2026
- DRS/A Draft registration statement, submitted confidentially, amended Feb 12, 2026
- DRS Draft registration statement, submitted confidentially Dec 19, 2025
Everything here comes from Attovia Therapeutics, Inc.'s own filings on SEC EDGAR. The filing list is rechecked every hour.